Skip to content

Investigating the effect of Lactuca sativa syrup consumption on indicators of breast milk sufficiency and breastfeeding success among neonates

Investigating the effect of Lactuca sativa syrup consumption on indicators of breast milk sufficiency and breastfeeding success among neonates

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180427039436N14
Enrollment
105
Registered
2025-01-21
Start date
2025-04-20
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Investigating the effect of Lactuca sativa syrup consumption on indicators of breast milk sufficiency and breastfeeding success among neonates.

Interventions

Intervention 1: Intervention group: Mothers in the test group will receive 4 pieces of lettuce syrup and they are advised to consume one tablespoon three times a day, half an hour after breakfast, lun

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Criteria for entering the mother's study: Being of Iranian origin Ability to read and write Exclusive breastfeeding singleton pregnancy 18 years of age or older Mother's body mass index (19/8-26 kg/m2) Living with a spouse Criteria for entering the study of newborns: Term baby of 37-42 weeks of pregnancy with birth weight between 2500 and 4000 grams

Exclusion criteria

Exclusion criteria: Criteria for not entering the mother's study: Use of other supplements History of infertility Endocrine problems including diabetes or thyroid disorders Breast problems such as abscess, inverted nipple, mastitis or cancer, breast congestion History of cosmetic breast surgery, such as placing a prosthesis Taking certain drugs such as phenobarbital and ergotamine Suffering from diseases such as asthma, coagulation disorders, cardiovascular diseases, high blood pressure and digestive diseases. Use of dopamine antagonists (domperidone, metoclopramide, risperidone, and phenothiazine) History of using psychiatric drugs, warfarin, aspirin or hormones in the last year The presence of any known and known diseases in the mother that cause contraindications for breastfeeding (such as HIV and active pulmonary tuberculosis) History of known mental illnesses based on mother's report Having stressful situations in life such as the death of loved ones in the last three months Smoking, alcohol and drugs, drug abuse Criteria for not entering the study of the baby: Contraindication to breastfeeding due to the presence of any known underlying disease in the baby (such as cleft lip/palate)

Design outcomes

Primary

MeasureTime frame
Determining the success rate of breastfeeding. Timepoint: The end of the study (the end of the fourth week of the study). Method of measurement: Using a 21-item questionnaire of breastfeeding success.;Determining breast milk adequacy indicators. Timepoint: Day 1, end of second week, end of fourth week. Method of measurement: Breast milk adequacy is evaluated by measuring the indicators of feeding frequency, number of wet diapers, daily bowel movements and growth measurement parameters (height, weight and head circumference).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Amiri Farahani

Iran University of Medical Sciences

l.amirifarahani1100@gmail.com+98 21 4365 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026